The FDA apparently deems an uncontrolled study acceptable – five months after saying no.
ApexOnco Front Page
Recent articles
Could RO7851624, newly into clinical trials, be RG6735?
Global data are in the same ballpark as Chinese results presented earlier this year.
The latest projects newly into human trials include BNT3212.
But results come from a curated dataset, with no in-trial comparator.
A common mutation comes into play for PRMT5 inhibition.
Early data with IDE849 look better those with Zai’s zocilurtatug pelitecan.
Investors now have more reasons to doubt Harmoni's ability to back US approval.